Paenilamicins are
a group of complex polycationic peptide secondary
metabolites with antibacterial and antifungal activities produced
by the devastating honey bee brood pathogen Paenibacillus
larvae causing the lethal brood disease American Foulbrood
(AFB). Here, we report the convergent total synthesis and structural
revision of paenilamicin B2. Specific stereoisomers of paenilamicin
B2 were synthesized for unambiguous confirmation of the natural product
structure and for evaluation of biological activities. These studies
revealed the N-terminal fragment of paenilamicin as an important pharmacophore.
Infection assays using bee larvae and the insect pathogen Bacillus thuringiensis demonstrated that paenilamicins outcompete
bacterial competitors in the ecological niche of P. larvae. Finally, we show first data that classifies paenilamicins as potential
ribosome inhibitors. Hence, our synthesis route is a further step
for understanding the pathogenicity of P. larvae and
for thorough structure–activity-relationship as well as mode-of-action
studies in the near future.